Literature DB >> 6155347

Biochemical and morphological characterization of the killing of human monocytes by a leukotoxin derived from Actinobacillus actinomycetemcomitans.

N S Taichman, R T Dean, C J Sanderson.   

Abstract

A potent, heat-labile leukotoxic material was extracted from Actinobacillus actinomycetemcomitans (strain Y4), an anaerobic gram-negative microorganism originally isolated from subgingival plaque in a patient with juvenile periodontitis. The cytopathic effects of Y4 toxin on purified monocytes were studied by the extracellular release of radioactive cytoplasmic markers and cell enzymes and by time-lapse microcinematography. Y4 toxin rapidly bound to the cells, producing dose- and time-dependent alterations culminating in cell death and release of intracellular constituents into the culture medium. The evidence to be presented suggests that the cell membrane of the monocyte may be the primary target in the development of these phenomena. Previous studies have shown that Y4 toxin also kills human polymorphonuclear leukocytes but not other cell types. It is conceivable that disruption of polymorphonuclear leukocytes and monocytes by Y4 toxin in the gingival crevice area may be relevant in the pathogenesis of juvenile periodontitis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6155347      PMCID: PMC550921          DOI: 10.1128/iai.28.1.258-268.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Histological changes in experimental periodontal disease in rats mono-infected with a gram-negative organism.

Authors:  J T Irving; M G Newman; S S Socransky; J D Heely
Journal:  Arch Oral Biol       Date:  1975-03       Impact factor: 2.633

2.  Effects of anti-inflammatory and other compounds on the release of lysosomal enzymes from macrophages.

Authors:  P S Ringrose; M A Parr; M McLaren
Journal:  Biochem Pharmacol       Date:  1975-03-01       Impact factor: 5.858

3.  Demonstration that monocytes rather than lymphocytes are the insulin-binding cells in preparations of humah peripheral blood mononuclear leukocytes: implications for studies of insulin-resistant states in man.

Authors:  R H Schwartz; A R Bianco; B S Handwerger; C R Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

Review 4.  Ultrastructure of membrane lesions in immune lysis, osmotic lysis and drug-induced lysis.

Authors:  P Seeman
Journal:  Fed Proc       Date:  1974-10

Review 5.  Membrane fusion.

Authors:  G Poste; A C Allison
Journal:  Biochim Biophys Acta       Date:  1973-12-28

Review 6.  Participation of mononuclear phagocytes in chronic inflammatory diseases.

Authors:  R C Page; P Davies; A C Allison
Journal:  J Reticuloendothel Soc       Date:  1974-05

7.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

8.  Effects of dental plaque on the production and release of lysosomal hydrolases by macrophages in culture.

Authors:  R C Page; P Davies; A C Allison
Journal:  Arch Oral Biol       Date:  1973-12       Impact factor: 2.633

Review 9.  Pathogenesis of inflammatory periodontal disease. A summary of current work.

Authors:  R C Page; H E Schroeder
Journal:  Lab Invest       Date:  1976-03       Impact factor: 5.662

10.  Cytochalasin B reversibly inhibits phagocytosis: functional, metabolic, and ultrastructural effects in human blood leukocytes and rabbit alveolar macrophages.

Authors:  S E Malawista; J B Gee; K G Bensch
Journal:  Yale J Biol Med       Date:  1971-12
View more
  58 in total

1.  Secretion of RTX leukotoxin by Actinobacillus actinomycetemcomitans.

Authors:  S C Kachlany; D H Fine; D H Figurski
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

2.  Regulation of leukotoxin in leukotoxic and nonleukotoxic strains of Actinobacillus actinomycetemcomitans.

Authors:  J Spitznagel; E Kraig; D Kolodrubetz
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

3.  The cytolethal distending toxin induces receptor activator of NF-kappaB ligand expression in human gingival fibroblasts and periodontal ligament cells.

Authors:  G N Belibasakis; A Johansson; Y Wang; C Chen; S Kalfas; U H Lerner
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

4.  Leukotoxin confers beta-hemolytic activity to Actinobacillus actinomycetemcomitans.

Authors:  Nataliya V Balashova; Juan A Crosby; Lourdes Al Ghofaily; Scott C Kachlany
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

5.  Actinobacillus actinomycetemcomitans toxin induces both cell cycle arrest in the G2/M phase and apoptosis.

Authors:  M Ohguchi; A Ishisaki; N Okahashi; M Koide; T Koseki; K Yamato; T Noguchi; T Nishihara
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

6.  Differential regulation of the leukotoxin operon in highly leukotoxic and minimally leukotoxic strains of Actinobacillus actinomycetemcomitans.

Authors:  M Hritz; E Fisher; D R Demuth
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

7.  Cloning and expression of the leukotoxin gene from Actinobacillus actinomycetemcomitans.

Authors:  D Kolodrubetz; T Dailey; J Ebersole; E Kraig
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

Review 8.  Aggregatibacter actinomycetemcomitans leukotoxin: From mechanism to targeted anti-toxin therapeutics.

Authors:  Eric Krueger; Angela C Brown
Journal:  Mol Oral Microbiol       Date:  2020-03-10       Impact factor: 3.563

9.  Studies of leukotoxin from Actinobacillus actinomycetemcomitans using the promyelocytic HL-60 cell line.

Authors:  J J Zambon; C DeLuca; J Slots; R J Genco
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

10.  Regulation of Actinobacillus actinomycetemcomitans leukotoxin expression: analysis of the promoter regions of leukotoxic and minimally leukotoxic strains.

Authors:  J M Brogan; E T Lally; K Poulsen; M Kilian; D R Demuth
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.